NMTC
NeuroOne Medical·NASDAQ
--
--(--)
--
--(--)
5.38 / 10
Netural
With a fund flow rating of 7.3/10, the stock shows robust fund flow characteristics. Supportive momentum from Large trends is partially offset by concerning overall, block, Small, Medium, and Extra-large patterns, pointing to positive capital flow trajectory. Analyst sentiment reflects overwhelmingly bullish analyst consensus with strong conviction. The rating profile includes Strong Buy(100.0%) from 1 analytical reports, supported by 3.47 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-09-09
InstitutionMaxim Group
Times predicted1
Historical Win Rate100.0%
What is the market sentiment for NMTC?
- NMTC holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.38/10 (Netural).
